TOIIW Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,890,784.61

Oncology Institute Insider Trading History Chart

This chart shows the insider buying and selling history at Oncology Institute by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncology Institute Share Price & Price History

Current Price: $0.13
Price Change: Price Increase of +0.005 (4.16%)
As of 12/2/2022 10:01 PM ET

This chart shows the closing price history over time for TOIIW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
🚨 [Strong Buy Alert] Is this laser stock in your portfolio?
There are very few opportunities like this in today's bear market...

But our analysts identified a tiny defense company landing billions of dollars in contracts every year.
Get the name of the company here >>>

Oncology Institute Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2022Mohit KaushalDirectorSell15,994$2.13$34,067.2225,534View SEC Filing Icon  
11/11/2022Havencrest Healthcare PartnersMajor ShareholderSell365,321$2.33$851,197.9313,362,873View SEC Filing Icon  
11/9/2022Havencrest Healthcare PartnersMajor ShareholderSell80,000$3.09$247,200.0013,789,475View SEC Filing Icon  
11/7/2022Havencrest Healthcare PartnersMajor ShareholderSell19,167$3.28$62,867.7613,896,475View SEC Filing Icon  
11/4/2022Havencrest Healthcare PartnersMajor ShareholderSell50,200$3.39$170,178.0013,915,642View SEC Filing Icon  
11/2/2022Havencrest Healthcare PartnersMajor ShareholderSell58,500$3.94$230,490.0014,011,342View SEC Filing Icon  
10/31/2022Havencrest Healthcare PartnersMajor ShareholderSell41,855$4.69$196,299.9514,120,114View SEC Filing Icon  
10/28/2022Havencrest Healthcare PartnersMajor ShareholderSell52,091$4.84$252,120.4414,161,969View SEC Filing Icon  
10/26/2022Havencrest Healthcare PartnersMajor ShareholderSell52,500$5.16$270,900.0014,249,060View SEC Filing Icon  
10/24/2022Havencrest Healthcare PartnersMajor ShareholderSell29,400$4.98$146,412.0014,331,960View SEC Filing Icon  
10/24/2022Mohit KaushalDirectorSell4,798$4.96$23,798.0841,528View SEC Filing Icon  
10/21/2022Havencrest Healthcare PartnersMajor ShareholderSell20,000$4.96$99,200.0014,361,360View SEC Filing Icon  
10/19/2022Havencrest Healthcare PartnersMajor ShareholderSell17,500$4.68$81,900.0014,393,360View SEC Filing Icon  
10/17/2022Havencrest Healthcare PartnersMajor ShareholderSell8,249$4.60$37,945.4014,423,060View SEC Filing Icon  
10/14/2022Havencrest Healthcare PartnersMajor ShareholderSell9,800$4.54$44,492.0014,431,309View SEC Filing Icon  
10/12/2022Havencrest Healthcare PartnersMajor ShareholderSell14,343$4.70$67,412.1014,466,309View SEC Filing Icon  
10/10/2022Havencrest Healthcare PartnersMajor ShareholderSell21,500$4.33$93,095.0014,505,652View SEC Filing Icon  
10/7/2022Havencrest Healthcare PartnersMajor ShareholderSell14,652$4.63$67,838.7614,527,152View SEC Filing Icon  
10/5/2022Havencrest Healthcare PartnersMajor ShareholderSell14,060$4.78$67,206.8014,575,313View SEC Filing Icon  
10/3/2022Havencrest Healthcare PartnersMajor ShareholderSell16,765$4.72$79,130.8014,612,820View SEC Filing Icon  
9/30/2022Havencrest Healthcare PartnersMajor ShareholderSell11,000$4.68$51,480.0014,629,585View SEC Filing Icon  
9/28/2022Havencrest Healthcare PartnersMajor ShareholderSell12,642$4.72$59,670.2414,661,585View SEC Filing Icon  
9/26/2022Havencrest Healthcare PartnersMajor ShareholderSell7,153$4.57$32,689.2114,688,301View SEC Filing Icon  
9/22/2022Havencrest Healthcare PartnersMajor ShareholderSell13,086$4.25$55,615.5014,700,829View SEC Filing Icon  
9/19/2022Havencrest Healthcare PartnersMajor ShareholderSell19,629$4.33$84,993.5714,713,915View SEC Filing Icon  
9/16/2022Havencrest Healthcare PartnersMajor ShareholderSell200,000$4.50$900,000.0014,733,544View SEC Filing Icon  
9/14/2022Havencrest Healthcare PartnersMajor ShareholderSell37,785$4.99$188,547.1515,002,044View SEC Filing Icon  
9/12/2022Havencrest Healthcare PartnersMajor ShareholderSell38,000$5.52$209,760.0015,092,329View SEC Filing Icon  
9/9/2022Havencrest Healthcare PartnersMajor ShareholderSell18,900$5.80$109,620.0015,130,329View SEC Filing Icon  
9/7/2022Havencrest Healthcare PartnersMajor ShareholderSell45,000$6.04$271,800.0015,172,729View SEC Filing Icon  
8/31/2022Havencrest Healthcare PartnersMajor ShareholderSell25,000$6.36$159,000.0015,375,212View SEC Filing Icon  
8/29/2022Havencrest Healthcare PartnersMajor ShareholderSell15,000$6.14$92,100.0015,438,712View SEC Filing Icon  
8/26/2022Havencrest Healthcare PartnersMajor ShareholderSell40,000$6.03$241,200.0015,453,712View SEC Filing Icon  
8/24/2022Havencrest Healthcare PartnersMajor ShareholderSell21,084$6.37$134,305.0815,497,237View SEC Filing Icon  
8/22/2022Havencrest Healthcare PartnersMajor ShareholderSell35,500$6.53$231,815.0015,566,421View SEC Filing Icon  
8/19/2022Havencrest Healthcare PartnersMajor ShareholderSell10,873$6.81$74,045.1315,601,921View SEC Filing Icon  
8/15/2022Havencrest Healthcare PartnersMajor ShareholderSell16,663$6.23$103,810.4915,621,231View SEC Filing Icon  
8/12/2022Havencrest Healthcare PartnersMajor ShareholderSell24,900$6.69$166,581.0015,637,894View SEC Filing Icon  
5/11/2022Richy AgajanianMajor ShareholderSell1,600,000$6.00$9,600,000.00253,436View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncology Institute (NASDAQ:TOIIW)

Oncology Institute Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/3/2022Wolverine Asset Management LLC118,666$59K0.0%+29.0%0.000%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.50,000$58K0.0%-52.6%0.000%Search for SEC Filing on Google Icon
5/4/2022Wolverine Asset Management LLC91,966$0.11M0.0%-18.8%0.000%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Oncology Institute logo
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
Read More on Oncology Institute

Today's Range

Now: $0.13
Low: $0.13
High: $0.13

50 Day Range

MA: $0.45
Low: $0.12
High: $0.80

52 Week Range

Now: $0.13
Low: $0.12
High: $1.50


1,000 shs

Average Volume

18,036 shs

Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Oncology Institute?

Oncology Institute's top insider investors include:
  1. Havencrest Healthcare Partners (Major Shareholder)
  2. Richy Agajanian (Major Shareholder)
  3. Mohit Kaushal (Director)
Learn More about top insider investors at Oncology Institute.